Pyrsopoulos, Nikolaos <br/><br/>
The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data.  [electronic resource] 

 -  European journal of gastroenterology & hepatology  07 2018 
 - 761-765 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1473-5687 
<br/><br/><label>Standard No.: </label>10.1097/MEG.0000000000001101  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--adverse effects<br/>Benzimidazoles--adverse effects<br/>Female<br/>Fluorenes--adverse effects<br/>Hepacivirus--drug effects<br/>Hepatitis C--diagnosis<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Liver Cirrhosis--diagnosis<br/>Liver Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Retrospective Studies<br/>Ribavirin--adverse effects<br/>Sofosbuvir<br/>Sustained Virologic Response<br/>Time Factors<br/>Treatment Outcome<br/>Uridine Monophosphate--adverse effects<br/>Virus Activation--drug effects